Formulation and Stabilization of Biotherapeutics

preview_player
Показать описание

#MITPROFESSIONALEDUCATION #MITSHORTPROGRAMS
  1. MIT Professional Education
Рекомендации по теме
Formulation and Stabilization 0:02:47

Formulation and Stabilization of Biotherapeutics

Optimizing stability during 0:12:14

Optimizing stability during the formulation of therapeutic proteins

Polysorbates and Related 0:56:01

Polysorbates and Related Surfactants in Bioprocessing and Biotherapeutic Formulations - Dr Stephen R

Vaccine and Biotherapeutic 0:59:22

Vaccine and Biotherapeutic Formulation Development and Manufacture Using Spray-Drying

Live Biotherapeutics - 0:11:01

Live Biotherapeutics - Creative Biolabs

DEVELOPABILITY ASSESSMENT OF 1:04:01

DEVELOPABILITY ASSESSMENT OF THERAPEUTIC PROTEINS – A TOOLBOX FOR TACKLING INCREASING COMPLEXITY

Extending Shelf Life 0:12:21

Extending Shelf Life Of Therapeutic Proteins With Hydroxylpropyl Β Cyclodextrins-japanese subtitle

Developability Assessment of 1:04:19

Developability Assessment of Therapeutic Proteins – A Toolbox for Tackling Increasing Complexity

Engineered Particles for 0:57:32

Engineered Particles for Inhaled Biotherapeutics

Measuring stability to 0:23:45

Measuring stability to more effectively select therapeutic antibody candidates

Effect of saRNA 0:20:03

Effect of saRNA Formulation on Protein Expression and Vaccine Immunology

12 Pharmaceutical Development 2:25:42

12 Pharmaceutical Development and Manufacturing APV session

MIT FORMULATIONS 0:00:55

MIT FORMULATIONS

Exploring Possibilities for 1:02:41

Exploring Possibilities for Biotherapeutics in Pharma 4 0

Lyophilized Drug Product 0:02:55

Lyophilized Drug Product Development: An Industry Perspective

Using Engineered Particles 0:53:13

Using Engineered Particles in Capsules for Rapid-to-Clinic Dry Powder Inhalation Applications

Spray Dried Biologics: 1:02:15

Spray Dried Biologics: Formulation and Process Considerations

Anastasia Khvorova: RNAi-based 0:59:20

Anastasia Khvorova: RNAi-based Therapeutics: 2018 Outlook

Building Robustness and 0:49:09

Building Robustness and Transferability in Modern Size-Exclusion Methods

#12 - Pascal 0:17:09

#12 - Pascal Touchon, President and CEO at Atara Biotherapeutics

Mischievous membrane proteins 0:25:41

Mischievous membrane proteins (and how to tame them)

Robert Higham, Executive 0:08:02

Robert Higham, Executive Director with Arcutis Biotherapeutics with Jennifer Conner - MPAS, PAC

Trends and challenges 0:17:11

Trends and challenges in glycobiology: biophysical tools to advance your molecular studies

Prof. Dr. Hans 0:01:05

Prof. Dr. Hans Curt Flemming interview - International Biofilm Summit